Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan

Japanese Journal of Infectious Diseases

Volumn 58, Issue 2, 2005, Pages 83-87

  Mizuochi, Toshiaki ^b   Okada, Yoshiaki ^b   Umemori, Kiyoko ^b   Mizusawa, Saeko ^b   Sato, Shinichiro ^a   Yamaguchi, Kazunari ^b  

^a JAPANESE RED CROSS SOCIETY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ANTIGEN;

ARTICLE; CHEMOLUMINESCENCE; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; JAPAN; PREVALENCE; SENSITIVITY ANALYSIS;

GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOASSAY; JAPAN; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 19944389259     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Le Bouvier, G. L. (1971): The heterogeneity of Australia antigen. J. Infect. Dis., 123, 671-675.
2. Bancroft, W. H., Mundon, F. K. and Russel, P. K. (1972): Detection of additional antigenic determinants of hepatitis B antigen. J. Immunol., 109, 842-848.
3. Coleman, P. F., Chen, Y.-C. J. and Mushahwar, I. K. (1999): Immunoassay Detection of hepatitis B surface antigen mutants. J. Med. Virol., 59, 19-24.
4. Okamoto, H., Tsuda, F., Sakugawa, H., Sastrosoewignjo, R. I., Imai, M., Miyakawa, Y. and Mayumi, M. (1988): Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol., 69, 2575-2583.
5. Norder, H., Courouce, A. M. and Magnius, L. O. (1994): Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology, 198, 489-503.
6. Stuyver, L., De Gendt, S., Van Geyt, C., Zoulim, F., Fried, M., Schinazi, R. F. and Rossau, R. (2000): A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol., 81, 67-74.
7. Arauz-Ruiz, P., Norder, H., Robertson, B. H. and Magnius, L. O. (2002): Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol., 83, 2059-2073.
8. Magnius, L. O. and Norder, H. (1995): Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology, 38, 24-34.
9. Chu, C. J. and Lok, A. S. F. (2002): Clinical significance of hepatitis B virus genotypes. Hepatology, 35, 1274-1276.
10. Fung, S. K. and Lok, A. S. F. (2004): Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection? Hepatology, 40, 790-792.
11. Kobayashi, M., Arase, Y., Ikeda, K., Tsubota, A., Suzuki, Y., Hosaka, T., Saito, S., Kobayashi, M., Suzuki, F., Akuta, N., Someya, T., Matsuda, M., Sato, J. and Kumada, H. (2003): Clinical feature of hepatitis B virus genotype A in Japanese patients. J. Gastroenterol., 38, 656-662.
12. Mayerat, C., Mantgegani, A. and Frei, P. C. (1999): Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J. Viral. Hepat., 6, 299-304.
13. Kao, J. H., Chen, P. J., Lai, M. Y. and Chen, D. S. (2000): Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology, 118, 554-559.
14. Orito, E. and Mizokami, M. (2003): Hepatitis B virus genotypes and hepatocellular carcinoma in Japan. Intervirology, 46, 408-412.
15. Kao, J. H., Wu, N. H., Chen, P. J., Lai, M. Y. and Chen, D. S. (2000): Hepatitis B genotypes and the response to interferon therapy. J. Hepatol., 33, 998-1002.
16. Wai, C. T., Chu, C. J., Hussain, M. and Lok, A. S. (2002): HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C. Hepatology, 36, 1425-1430.
17. Kao, J. H., Liu, C. J. and Chen, D. S. (2002): Hepatitis B viral genotypes and lamivudine resistance. J. Hepatol., 36, 303-304.
18. Zollner, B., Petersen, J., Puchhammer-Stockl, E., Kletzmayr, J., Sterneck, M., Fischer, L., Schroeter, R. and Feucht, H. H. (2004): Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology, 39, 42-50.
19. Günther, S., Li, B.-C., Miska, S., Kruger, D. H., Meisel, H. and Will, H. (1995): A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol., 69, 5437-5444.
20. Food and Drug Administration, U. S. (2004): Guidance for Industry. A modified lot-release specification for hepatitis B surface antigen (HBsAg) assays used to test blood, blood components, and source plasma donations. April 2004.
21. European Union (1998): Common Technical Specifications (CTS) for products defined in Annex II, List A of Directive 98/79/EC: CTS for the manufacturer's release testing of reagents and reagent products for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C, D (Immunological assays only).
22. Ireland, J. H., O'Donnell, B., Basuni, A. A., Kean, J. D., Wallace, L. A., Lau, G. K. K. and Carman, W. F. (2000): Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology, 31, 1176-1182.
23. Zaaijer, H. L., Vrielink, H. and Koot, M. (2001): Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays. Vox Sang., 81, 219-221.
24. Levicnik-Stezinar, S. (2004): Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin. Lab., 50, 49-51.
25. Moerman, B., Moons, V., Sommer, H., Schmitt, Y. and Stetter, M. (2004): Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin. Lab., 50, 159-162.